These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8411227)

  • 1. Clinical trial reimbursement reform sought.
    Parkins T
    J Natl Cancer Inst; 1993 Oct; 85(19):1549-51. PubMed ID: 8411227
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of health care reform on reimbursement for investigational therapy.
    Turner S
    Cancer Invest; 1993; 11(1):68-9. PubMed ID: 8422599
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursement for clinical investigation.
    Oldham RK
    Pharos Alpha Omega Alpha Honor Med Soc; 1991; 54(2):33. PubMed ID: 2068219
    [No Abstract]   [Full Text] [Related]  

  • 4. Breakout II. Reimbursement concerns.
    Henney JE; Greene T; Aronson N; Johnson JE; McCabe M; Monaco GP; Poulter CA
    Cancer; 1990 May; 65(10 Suppl):2409-10. PubMed ID: 2334881
    [No Abstract]   [Full Text] [Related]  

  • 5. Reimbursement issues in cancer clinical trials.
    McKenna RJ
    Cancer; 1990 May; 65(10 Suppl):2405-6. PubMed ID: 2346567
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers to clinical trials. Part I: Reimbursement problems.
    Fleming ID
    Cancer; 1994 Nov; 74(9 Suppl):2662-5. PubMed ID: 7954282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-party payers and investigational therapy.
    N Engl J Med; 1988 Nov; 319(18):1228. PubMed ID: 3173464
    [No Abstract]   [Full Text] [Related]  

  • 8. Who pays for clinical research?
    Weiss GB
    Clin Res; 1979 Oct; 27(4):297-9. PubMed ID: 10309043
    [No Abstract]   [Full Text] [Related]  

  • 9. Insurance coverage for clinical investigation.
    Smith SP
    Pharos Alpha Omega Alpha Honor Med Soc; 1991; 54(1):34. PubMed ID: 2006206
    [No Abstract]   [Full Text] [Related]  

  • 10. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 12. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 13. Financial help for research subjects enrolled in "approved clinical studies".
    Maloney DM
    Hum Res Rep; 2001 Apr; 16(4):9. PubMed ID: 11883457
    [No Abstract]   [Full Text] [Related]  

  • 14. The crisis in clinical cancer research. Third-party insurance and investigational therapy.
    Antman K; Schnipper LE; Frei E
    N Engl J Med; 1988 Jul; 319(1):46-8. PubMed ID: 3288868
    [No Abstract]   [Full Text] [Related]  

  • 15. Providers win device-payment fight.
    Scott L
    Mod Healthc; 1995 Sep; 25(38):17. PubMed ID: 10151394
    [No Abstract]   [Full Text] [Related]  

  • 16. Reimbursement for patients enrolled in clinical trials.
    Kennedy BJ
    Cancer Invest; 1994; 12(4):444-6. PubMed ID: 8032968
    [No Abstract]   [Full Text] [Related]  

  • 17. Payer coverage for patients enrolled onto clinical trials: making the process easy and transparent for everyone.
    Palackdharry CS; Evans DL; McDonough RS; Clarke ME; Cross JD; Klein IM; Reisman L
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP91-7. PubMed ID: 22693988
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials: are they a good buy?
    Bennett CL; Adams JR; Knox KS; Kelahan AM; Silver SM; Bailes JS
    J Clin Oncol; 2001 Dec; 19(23):4330-9. PubMed ID: 11731516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical insurance aspects of human experiments].
    Staak M
    Lebensversicher Med; 1979 Jan; 32(1):12-6. PubMed ID: 43933
    [No Abstract]   [Full Text] [Related]  

  • 20. Hospitals try to devise solutions in device debate.
    Scott L
    Mod Healthc; 1995 Feb; 25(8):34-6, 38. PubMed ID: 10140204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.